Rekombinanter Involucrin Antikörper (full length)

Produktnummer ABIN7878462

Der Maus Monoklonal anti-Involucrin Antikörper wird verwendet zum Nachweis von Involucrin in Proben von Human. Er wurde validiert für IHC (p).

Kurzübersicht für Rekombinanter Involucrin Antikörper (full length) (ABIN7878462)

Target: Involucrin (IVL)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Involucrin Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Güteklasse: Carrier-free

Klon: RIVRN-9323

Produktdetails anti-Involucrin Antikörper

Bindungsspezifität: full length

Verwendungszweck: Recombinant IVL Antibody / Involucrin (azide and preservative free)

Aufreinigung: Protein A/G affinity

Immunogen: Recombinant human full-length Involucrin protein was used as the immunogen for the recombinant IVL antibody.

Isotyp: IgG2b, kappa

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the recombinant IVL antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Konservierungsmittel: Azide free

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the recombinant IVL antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu Involucrin

Target: Involucrin (IVL)

Andere Bezeichnung: IVL

Hintergrund: It recognizes a protein of 66 kDa-170 kDa, identified as involucrin. In Western blotting of cultured human keratinocytes, this MAb reacts with a 120 kDa protein. It stains the involucrin in a variety of sizes: 170 kDa in MCF-7 cells, a doublet of ~115 kDa and 150 kDa in gorilla and owl monkey, 66 kDa in dog, and a doublet of 105 kDa in pig. Its epitope maps between codon 421-568 of human involucrin. Involucrin is expressed in a range of stratified squamous epithelia, including the cornea, which lacks a distinct cornified layer. In normal epidermis, it is first expressed in the upper spinous layers, and in keratinocyte cultures, all cells that have left the basal layer express it. Involucrin expression is altered in pathological conditions: in psoriasis and other benign epidermal hyperplasias, involucrin expression begins closer to the basal layer than normal, expression is abnormal in squamous cell carcinomas and premalignant lesions, and is reduced in severe dysplasias of the larynx and cervix.

UniProt: P07476